Zhejiang Jiuzhou Pharmaceutical Co., Ltd

SSE:603456.SS

15.44 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 5,160.5855,523.4185,445.1054,063.1822,647.2842,016.8161,862.2251,717.4411,653.1771,444.5111,286.2071,309.5841,143.42935.11833.379652.529590.67
Cost of Revenue 3,417.1693,524.3623,557.8162,709.0511,654.391,314.21,241.7111,182.2711,231.027974.668926.141908.03800.305646.444573.055458.269422.258
Gross Profit 1,743.4161,999.0561,887.2891,354.131992.894702.616620.514535.17422.151469.843360.066401.554343.114288.666260.324194.26168.412
Gross Profit Ratio 0.3380.3620.3470.3330.3750.3480.3330.3120.2550.3250.280.3070.30.3090.3120.2980.285
Reseach & Development Expenses 314.912330.828287.379173.359114.22994.50287.15185.24576.39176.80354.47760.31157.3942.651000
General & Administrative Expenses 122.697142.18796.45580.20578.88574.38578.96251.45950.10547.52926.07631.30832.49729.313105.90785.50481.852
Selling & Marketing Expenses 44.80137.13257.50448.9740.94643.19832.11829.53527.42123.22821.40521.77320.0518.84615.26111.59610.648
SG&A 167.497488.426153.959129.176119.83117.583111.07980.99377.52570.75747.48153.08152.54748.159121.16897.192.5
Other Expenses 528.820332.315253.428224.183180.925-17.234-1.39516.87722.70837.0337.0589.8616.0861.7672.5822.185
Operating Expenses 1,011.23904.153773.653555.963458.242393.01367.13316.586299.31284.497201.229196.296174.579144.785125.02102.17497.412
Operating Income 732.1861,175.7711,107.912753.635456.149285.437193.741175.636119.083216.764124.206193.552149.904127.962123.81281.4549.085
Operating Income Ratio 0.1420.2130.2030.1850.1720.1420.1040.1020.0720.150.0970.1480.1310.1370.1490.1250.083
Total Other Income Expenses Net -1.5844.871-4.149-8.896-6.2471.484-1.146-1.39513.30313.7636.004-1.791-9.685.2790.6742.0561.044
Income Before Tax 730.6021,180.6421,103.822744.74449.902286.921192.595174.241132.525230.527157.502198.485158.855133.241124.48683.50650.129
Income Before Tax Ratio 0.1420.2140.2030.1830.170.1420.1030.1010.080.160.1220.1520.1390.1420.1490.1280.085
Income Tax Expense 123.535149.27183.272110.58970.01549.95736.67327.45421.1530.83520.39631.92322.19616.20313.95315.8578.062
Net Income 606.0961,033.256921.17633.901380.585237.793157.147147.605111.48200.079133.279166.241136.257117.05109.8667.21141.424
Net Income Ratio 0.1170.1870.1690.1560.1440.1180.0840.0860.0670.1390.1040.1270.1190.1250.1320.1030.07
EPS 0.681.161.110.770.470.30.20.190.140.250.220.30.240.210.410.250.16
EPS Diluted 0.681.161.110.760.470.30.20.180.140.250.220.30.240.210.410.250.16
EBITDA 1,160.5971,597.2811,477.7821,062.383744.775487.815372.335343.265293.709359.652251.669259.088219.594177.977135.30492.08681.605
EBITDA Ratio 0.2250.2890.2710.2610.2810.2420.20.20.1780.2490.1960.1980.1920.190.1620.1410.138